Cargando…
Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway
Integrin β1 (ITGB1) is frequently upregulated in ovarian cancer, and promotes ovarian tumorigenesis and cancer progression. However, the effects of ITGB1 inhibition on ovarian cancer progression and anticancer therapy remain to be elucidated. The results of the present study indicated that ITGB1 was...
Autores principales: | ZHANG, LEI, ZOU, WEN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758278/ https://www.ncbi.nlm.nih.gov/pubmed/26497667 http://dx.doi.org/10.3892/mmr.2015.4443 |
Ejemplares similares
-
SPP1 promotes ovarian cancer progression via Integrin β1/FAK/AKT signaling pathway
por: Zeng, Biao, et al.
Publicado: (2018) -
Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
por: Xu, B, et al.
Publicado: (2017) -
αν and β1 Integrins Mediate Aβ-Induced Neurotoxicity in Hippocampal Neurons via the FAK Signaling Pathway
por: Han, Hai-Yan, et al.
Publicado: (2013) -
Glucose Transporter 1 Promotes the Malignant Phenotype of Non-Small Cell Lung Cancer through Integrin β1/Src/FAK Signaling
por: Zhao, Huanyu, et al.
Publicado: (2019) -
β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway
por: Tian, Tao, et al.
Publicado: (2018)